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Background: Pleomorphic adenomas are benign 
tumors of the salivary glands that mainly affect the lower 
pole of the superficial lobe of the parotid gland. The term 
"pleomorphic" refers to the epithelial and connective origin 
of the mass. The clinical presentation is typically that of 
asymptomatic swelling which increases in volume. 
Therapy consists in surgical removal of the tumor mass by 
parotidectomy with nerve preservation. 
Case details: This clinical case describes an interesting 
case of pleomorphic adenoma of the parotid gland in a 62-
year-old patient. The patient presented with a long history 
of an asymptomatic mildly worsening swelling of the left 
parotid region. The peculiarity of the clinical case is the 
dimension of the adenoma (9x5x9 cm) and the presence of 
a thyroid incidentaloma (TI), consisting of a thyroid 
multinodular goiter composed of nodules, the largest of 
which measured 8 cm in diameter. This mass dislocated the 
laryngotracheal axis, compressed the larynx and caused the 
reduction of the respiratory space, making orotracheal 
intubation difficult and determining the need to perform a 
tracheotomy. 
Conclusion: Benign pleomorphic adenomas can 
potentially reach large sizes if untreated. Socio-economic 
problems may be the reason for late diagnosis.  
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I.  INTRODUCTION 
 
 Salivary gland tumors represent 1-3% of head and 
neck cancer, they mainly affect the parotid gland and 70-
80% are adenomas (1). Among benign neoplasms, the most 
frequent histotype is pleomorphic adenoma (PA). PA is 
more common in women with a male:female ratio of 1:2 
and is more prevalent between the fourth and sixth decade 
of life (2-6). 
PA is a mixed tumor that originates from epidermoid and 
myoepithelial cells; it includes mesenchymal tissues 
(myxoid, chondroid, mucoid) and epithelial tissues usually 
with adenomatous appearance (ducts, tubules, berries), 
hence the term "mixed tumor" (7, 8). PA is characterized 
by a slow but progressive growth and, if untreated, can 
reach a significant size (9), similarly to other benign head 
and neck masses such as lipoma (10). The diagnosis of PA 
PLEOMORPHIC ADENOMA OF THE PAROTID GLAND AND 
IPSILATERAL THYROID INCIDENTALOMA: REPORT OF A RARE 
CASE WITH REVIEW OF LITERATURE 
Candelori F1, Minni A1, Greco A1, Scarpa A2, Cassandro C3, Cavaliere M4, Bisogno A2, Cassandro 
E2, de Vincentiis M5 and Ralli M1 
 
1 Department of Sense Organs, University Sapienza of Rome, Italy 
2 Department of Medicine and Surgery, University of Salerno, Salerno, Italy 
3 Department of Surgical Sciences, University of Turin, Turin, Italy 
4Department of Otorhinolaryngology, University Hospital "San Giovanni di Dio e Ruggi D'Aragona", Salerno, Italy 
5 Department of Oral and Maxillo-Facial Surgery, University Sapienza of Rome, Italy 
 
(email corresponding authors: massimo.ralli@uniroma1.it)  
 
Translational Medicine @ UniSa - ISSN 2239-9747 2020, on line first(4): 15-18 
 
16 
Università degli Studi di Salerno 
is based on both clinical and radiological exams, including 
imaging techniques such as B-mode Ultrasound, Magnetic 
Resonance Imaging (MRI) and Computed Tomography 
(CT), followed by fine needle aspiration (FNA) for 
preoperatory cytological diagnosis (11, 12).  
PA can undergo malignant transformation to carcinoma ex-
pleomorphic adenoma (13-15); rarely it metastasizes 
without malignant transformation (16). 
Treatment of PA is surgical; recurrence may occur mainly 
due to intraoperative multifunctional cellular effusions and 
cellular dissemination caused by difficulty in completing 
removal of the pseudocapsule (17). Historically, the 
incidence of recurrence was estimated between 20% and 
40%; today, with the most modern parotidectomy 
techniques, recurrence is estimated around 2.5% (18-20). 
The management of recurrent pleomorphic adenoma of the 
parotid gland is challenging because the tumor is often 
multinodular and can be associated with lesions to the facial 




II.  Case Report 
 
A 62-year-old female patient was admitted to the 
Otolaryngology Department of our university hospital 
reporting a painless swelling of the parotid region appeared 
several years earlier and slowly increased in volume. 
The patient was suffering from high blood 
pressure, severe obesity (BMI: 37), permanent atrial 
fibrillation and iatrogenic hypothyroidism. The patient 
regularly assumed nebivolol, furosemide and 
levothyroxine. In 1999, the patient had undergone a left 
hemithyroidectomy for thyroid nodularity. 
Physical examination showed facial symmetry 
with normal movements of the face and eyes. The swelling 
in the left parotid region had a multilobular appearance and 
an elastic consistency; it was not painful on palpation and 
the overlying skin were hyperemic. 
Fibrolaryngoscopy showed a paralysis of the left 
hemilarynx, probably due to the previous thyroid surgery; 
respiratory space was reduced. The patient underwent CT 
scan with contrast agent that detected a solid 
hypervascularized mass in the superficial lobe of the left 
parotid gland measuring 9x5x9 cm (Figure 1 A). CT scan 
also revealed a thyroid incidentaloma (TI), a solid 
hypervascularized mass in the left thyroid lobe with 
multiple focal calcifications over 8 cm in diameter 















The trachea was strongly deflected on the right 
side, in association with compression of the left pyriform 
sinus and ipsilateral hemilarynx. Pathological lymph nodes 
were found in the left submandibular region. Ultrasound-
guided FNA confirmed the presence of a multinodular 
goiter with a TIR 2 lesion (non-malignant / benign lesion) 
according to the 2014 Italian Consensus for Classification 
and Reporting of Thyroid Cytology classification (22). 
Patient underwent a combined parotidectomy and 
thyroidectomy (Figure 2); a temporary tracheotomy was 













Histological examination of the parotid specimen 
revealed a capsulated, solid and cystic mass characterized 
by the presence of a wide squamous component containing 
partially calcified corneal cysts and by multifocal 
proliferation of epithelial cells, which formed structures 
that resembled glandular lumina and spindle-shaped 
myoepithelial cells bearing pale cytoplasm. A hyaline and 
chondromyxoid extracellular matrix was present. There 
was evidence of multiple granulomatous inflammation foci 
containing multinucleated giant cells, even within the 
capsule. The features of chondromyxoid foci and glando-
duttal differentiation and the low growth rate (ki67 <5%) 
confirmed the diagnosis of PA with extensive squamous 
metaplasia. The histological exam also revealed reactive 
nodes, negative for tumoral invasion. Histological 
examination of the thyroid mass showed multiple colloid 
nodules in both lobes, characteristic of multinodular goiter 
(23-25). The parenchyma had histological features of 
macro and microfollicular stroma, with areas of focal 
necrosis sclerosis and inflammatory infiltration. 
The patient had no postoperative complications; 
tracheostomy was removed 2 weeks after surgery and 
showed no recurrence of disease at regular follow up visits 
(1, 3, 6, 12 and 18 months after surgery). 
 
 
III.  DISCUSSION 
 
 
Figure 1: Facial Computed tomography scan with contrast agent 
of the head and neck. A) solid hypervascularized mass in the 
superficial lobe of the left parotid gland measuring 9x5x9 cm 
(white arrows. B) a solid hypervascularized mass in the left 
thyroid lobe with multiple focal calcifications over 8 cm in 
diameter (yellow arrow). 
 
 
Figure 2: Intraoperative image 
showing a capsulated, solid and 
cystic mass in the superficial lobe 
of the left parotid gland.  
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This case report shows an obese patient with a large PA 
who presented in a late stage of the disease. In addition, the 
patient presented a contextual finding of a TI, a MG whose 
largest nodule reached 8 cm in diameter. The presence of 
vocal fold paralysis probably due to previous 
hemithyroidectomy, the very voluminous MG and the 
displacement of the laryngotracheal axis complicated the 
surgical intervention.  
PA or benign mixed tumor is the most common salivary 
gland neoplasm; in 80% of cases it involves the parotid 
gland, in 8% the submandibular gland, and in 6% the minor 
salivary glands (5). Generally, PA involves the lower pole 
of the superficial lobe of the parotid gland, is not painful 
and presents solid consistency (5, 21, 26). Facial nerve 
palsy is a rare occurrence (27), and was not found in this 
patient despite the large size of the parotid mass.  
Although encapsulated, in some locations the capsule is not 
fully developed and expansile growth produces protrusions 
into the surrounding gland, which may lead to recurrences 
if the tumor is enucleated. In the present case, a radical 
parotidectomy was performed with removal of the 
pseudocapsule; no recurrence of the parotid mass was 
found during follow up.  
The dominant histologic feature found in this case of PA is 
the great heterogeneity. The epithelial elements resembling 
ductal cells or myoepithelial cells are arranged in duct 
formations, acini, irregular tubules, strands, or sheets of 
cells. These elements are typically dispersed within a 
mesenchyme-like background of loose myxoid tissue 
containing islands of cartilage and, rarely, foci of bone. 
Sometimes, the epithelial cells form well-developed ducts 
lined by cuboidal to columnar cells with an underlying 
layer of deeply chromatic, small myoepithelial cells. In 
other cases, there may be strands or sheets of myoepithelial 
cells. Islands of well-differentiated squamous epithelium 
may also be present. In most cases there is no epithelial 
dysplasia or evident mitotic activity. There is no difference 
in biologic behavior between the tumors composed largely 
of epithelial elements and those composed largely of 
seemingly mesenchymal elements (28).  
Malignant transformation occurs in nearly 3% of cases, is 
usually linked a long-standing, untreated condition and has 
to be suspected in case of pain, ulceration, spontaneous 
bleeding, superficial and/or deep tissue invasion, rapid 
growth and facial nerve alterations (29, 30). 
In conclusion, the present case shows a peculiar situation in 
which a PA and TI were found in the same patient at a very 
late stage. PA may reach significant sizes if untreated, and 
socio-economic problems can be a reason for late diagnosis 
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